These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Gastrointestinal blood loss on phenylbutazone and feprazone.
    Author: Macfarlane JD, Maisey MN, Grahame R, Burry HC.
    Journal: Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693.
    Abstract:
    Feprazone, a new anti-inflammatory drug, is a useful antirheumatic preparation which causes little gastrointestinal upset. This short cross-over study shows no significant gastrointestinal blood loss with either feprazone or phenylbutazone by the red-cell chromium-51 labelling method.
    [Abstract] [Full Text] [Related] [New Search]